Does KADCYLA Cause Malignant neoplasm progression? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with KADCYLA. This represents 3.3% of all adverse event reports for KADCYLA.
5
Reports of Malignant neoplasm progression with KADCYLA
3.3%
of all KADCYLA reports
3
Deaths
0
Hospitalizations
How Dangerous Is Malignant neoplasm progression From KADCYLA?
Of the 5 reports, 3 (60.0%) resulted in death.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KADCYLA. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does KADCYLA Cause?
Disease progression (32)
Febrile neutropenia (20)
Death (18)
Nausea (17)
Fatigue (15)
Metastases to central nervous system (9)
Pyrexia (9)
Dyspnoea (8)
Hypoaesthesia (8)
Weight decreased (8)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which KADCYLA Alternatives Have Lower Malignant neoplasm progression Risk?
KADCYLA vs KALBITOR
KADCYLA vs KALETRA
KADCYLA vs KANAMYCIN\KANAMYCIN A
KADCYLA vs KARDEGIC
KADCYLA vs KEPPRA